# Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold

> **NCT03915535** · PHASE4 · TERMINATED · sponsor: **Samuel Fortin** · enrollment: 9 (actual)

## Conditions studied

- Healthy Athletes

## Interventions

- **DIETARY_SUPPLEMENT:** Eicosapentaenoic acid + Docosahexaenoic acid
- **DIETARY_SUPPLEMENT:** Eicosapentaenoic acid

## Key facts

- **NCT ID:** NCT03915535
- **Lead sponsor:** Samuel Fortin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-19
- **Primary completion:** 2019-12-18
- **Final completion:** 2022-03-28
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Several impacts of COVID-19 on recruitment and organization
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03915535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03915535, "Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03915535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*